Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (86)

« Back to Publications

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial).

Knapp M. et al, (2017), Int J Geriatr Psychiatry, 32, 1205 - 1216

Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.

Singh I. et al, (2017), Lancet Psychiatry, 4, 419 - 426

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings.

Harrison JK. et al, (2016), Cochrane Database Syst Rev, 11

Ketamine: stimulating antidepressant treatment?

Malhi GS. et al, (2016), BJPsych Open, 2, e5 - e9

Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial.

Atherton N. et al, (2016), Trials, 17

Ketamine and other glutamate receptor modulators for depression in adults

Caddy C. et al, (2016), BJ Psych Advances, 22, 214 - 215

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults

McCloud TL. et al, (2016), BJ Psych Advances, 22

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.

Howard R. et al, (2015), Lancet Neurol, 14, 1171 - 1181

Pharmacological interventions for cognitive decline in people with Down syndrome.

Livingstone N. et al, (2015), Cochrane Database Syst Rev, 2015

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.

McCloud TL. et al, (2015), Cochrane Database Syst Rev

Ketamine and other glutamate receptor modulators for depression in adults.

Caddy C. et al, (2015), Cochrane Database Syst Rev

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults

Rendell JM. et al, (2015), Cochrane Database of Systematic Reviews, 2015

Ketamine and other glutamate receptor modulators for depression in adults

Amit BH. et al, (2015), Cochrane Database of Systematic Reviews, 2015

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting.

Harrison JK. et al, (2015), Cochrane Database Syst Rev

Pharmacological interventions for cognitive decline in people with Down syndrome

Livingstone N. et al, (2015), Cochrane Database of Systematic Reviews, 2015

Load More

1
2
3
4
5
6